Company
Caidya
Caidya is a different kind of CRO by design.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2022
- Customers
- Caidya primarily partners with small to mid-sized biotech and biopharma innovators
Record updated 18 September 2026
About
Caidya is a global CRO partner dedicated to helping biopharma innovators navigate the complexities of drug development with greater speed, certainty, and confidence. We specialize in the execution of complex clinical trials, including challenging therapeutic areas, innovative study designs, rare patient populations, and cross-border programs.
Funding snapshot
- Total raised
- $165MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Growth, $165M2025
Funding rounds
- Growth
- $165M2025, Company stated